Prognostic effect of tumor location in stage II and III colon cancer.

被引：0
|
作者：
Ozveren, Ahmet
Surmeli, Zeki Gokhan
Turgut, Asli
Karaca, Burcak
Karabulut, Bulent
Sanli, Ulus Ali
Uslu, Ruchan
机构：
[1] Ege Univ, Sch Med, Div Med Oncol, Izmir, Turkey
[2] Ege Univ, Sch Med, Izmir, Turkey
[3] Ege Univ, Izmir, Turkey
[4] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Izmir, Turkey
[5] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Bornova, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14652
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic Significance of the Immunoscore in Colon Cancer in Stage III
    Lorenz, Judith
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 114 - 114
  • [42] Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer
    Roth, Arnaud D.
    Delorenzi, Mauro
    Tejpar, Sabine
    Yan, Pu
    Klingbiel, Dirk
    Fiocca, Roberto
    d'Ario, Giovanni
    Cisar, Laura
    Labianca, Roberto
    Cunningham, David
    Nordlinger, Bernard
    Bosman, Fred
    Van Cutsem, Eric
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (21): : 1635 - 1646
  • [43] Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma
    Yasmeen Z. Qwaider
    Naomi M. Sell
    Caitlin E. Stafford
    Hiroko Kunitake
    James C. Cusack
    Rocco Ricciardi
    Liliana G. Bordeianou
    Vikram Deshpande
    Robert N. Goldstone
    Christy E. Cauley
    David L. Berger
    Annals of Surgical Oncology, 2021, 28 : 3408 - 3414
  • [44] Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma
    Qwaider, Y. Z.
    Sell, N. M.
    Goldstone, R. N.
    Cauley, C. E.
    Ricciardi, R.
    Bordeianou, L. G.
    Cusack, J. C.
    Kunitake, H.
    Berger, D. L.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S20 - S20
  • [45] Infiltrating Tumor Border Configuration is a Poor Prognostic Factor in Stage II and III Colon Adenocarcinoma
    Qwaider, Yasmeen Z.
    Sell, Naomi M.
    Stafford, Caitlin E.
    Kunitake, Hiroko
    Cusack, James C.
    Ricciardi, Rocco
    Bordeianou, Liliana G.
    Deshpande, Vikram
    Goldstone, Robert N.
    Cauley, Christy E.
    Berger, David L.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (06) : 3408 - 3414
  • [46] PROGNOSTIC FACTORS FOR PATIENTS WITH RECURRENT DISEASE IN STAGE II-III COLON CANCER
    Mateo, Joaquin
    Lopez-Doriga, Adriana
    Navarro, Matilde
    Martinez Villacampa, M. Mercedes
    Laquente, Berta
    Soler, Gemma
    Ramos, Emilio
    Biondo, Sebastiano
    Macia, Ivan
    Salazar, Ramon
    Santos, Cristina
    ANNALS OF ONCOLOGY, 2011, 22 : v107 - v107
  • [47] Association of gender-related tumor recurrence with a polymorphic variant of LMTK3 in stage II and III colon cancer.
    Zhang, Wu
    Gerger, Armin
    Labonte, Melissa Janae
    Yang, Dongyun
    Bohanes, Pierre Oliver
    Ning, Yan
    Winder, Thomas
    Wilson, Peter M. D.
    Benhaim, Leonor
    El-Khoueiry, Rita
    El-Khoueiry, Anthony B.
    Iqbal, Syma
    Giamas, Georgios
    Stebbing, Justin
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [48] Survival benefits of adjuvant chemotherapy in high-grade stage II and III colon cancer.
    Tsang, Walter
    Ziogas, Argyrios
    Nangia, Chaitali Singh
    Zell, Jason A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] A statewide evaluation of adjuvant chemotherapy for stage III colon cancer.
    Petrelli, N. J.
    Grubbs, S. S.
    Spellman, J. E.
    English, C. L.
    Shevock, A.
    Nunley, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] THE ASSOCIATION BETWEEN PRIMARY TUMOR LOCATION AND RISK FACTORS FOR RECURRENCE IN PATIENTS WHO UNDERWENT CURATIVE RESECTION FOR STAGE II COLON CANCER.
    Obana, A.
    Koyama, M.
    Kitamura, K.
    Matsumura, T.
    Karikomi, K.
    Suwa, T.
    DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E154 - E155
12345